Home | Contact | Sitemap | 中文 | CAS
   
Home News About Us Research People International Cooperation Graduate Education Papers Join Us
  International Cooperation
Introduction
Int'l Cooperation News
Location: Home > International Cooperation > Int'l Cooperation News

Impact of Absorption on Pharmacokinetic Variability
Author:
ArticleSource:
Time: 2009-06-09
Close
Text Size: A A A
Print

Yuji Kumagai, MD, PhD.
Director, Clinical Trial Center
Kitasato University East Hospital, Kanagawa, Japan
    Information of pharmacokinetic data in human is essential in drug development. Failure rate of investigational drugs in phase I trials is still approximately 10%, and microdose clinical trials are started in EU, US and Japan. The microdose trials principally aim at revealing absorption characteristics of a drug and we noticed several factors which may affect kinetics of drugs in microdose trials.  We also have several experiences of interesting pharmacokinetic data of phase I clinical trials in healthy and diseased subjects. Although original data cannot be presented by the obligation of contracts for some drugs, I'd like to share some information with Asian colleagues for the future benefits o f Asian people.

 
Copyright 2009 by Institute of Process Engineering, Chinese Academy of Sciences, All Right Reserved